Op-Ed: It's time for the greater Houston area to embrace connectivity

guest column

Every stakeholder should be at the table: industry, city officials, businesses, and most importantly, the local community, to support the expansion of the local 5G network. Photo via Getty Images

We live in a digital first world where the need for fast, reliable connectivity is not just something people want--it’s a necessity.

Connectivity plays a key role in every facet of life from economic development to public safety. Tomorrow’s innovations will rely on today’s infrastructure. That means cities and states must keep their eyes and efforts firmly fixed on the most up-to-date technology and prepare for modern wireless services, including 5G technology, the fifth-generation wireless system, in order to stay ahead of the curve.

Many of us have seen television commercials and internet ads touting the benefits 5G will bring, particularly as it relates to speed and reliability. But 5G is much more than speed. It will pave the way for innovation across a broad range of industries, injecting trillions into the global economy and ultimately changing the way we work, get around the city and live our lives. 5G connectivity will be able to process mass amounts of data with little to no latency, a requirement for the technology of tomorrow.

The economic impact will also be significant. A report from Accenture found that 5G will greatly benefit the Texas economy in the next five years, bringing Texas an estimated $235.8 billion in additional sales, $130.5B in new GDP and 1.35M in potential jobs.

Cities that embrace this coming technological boom will find themselves better prepared to tackle challenges and address the needs of their residents. Take public safety for example: 80 percent of 911 calls originate from mobile devices, which rely on a network of infrastructure – towers, small cells and fiber. 5G will enable seamless data transfer between first responders and dispatchers, including the exact location of a call as well as medical history to EMS. It will create a seamless network to properly communicate to other emergency services like fire and police departments. An estimated 10,000 lives could be saved each year if emergency response times were reduced by one minute.

Relevant to Pasadena are the transformations 5G will bring to healthcare and manufacturing. 5G is revolutionizing advanced training for medical professionals and allows more remote post-acute care and home-based models as well as enhanced communication between medical professionals. This will ultimately drive better patient outcomes and cost savings greater than 30 percent. 5G will also increase capacity and security for Pasadena’s wide variety of manufacturers, from chemicals to electronics to food and textiles, as well as create safer, smarter and more efficient processes that will drive continued innovation.

The full potential of 5G requires communications infrastructure–towers, small cells and fiber—and modernized regulations from local and state governments. Without the right infrastructure and policies in place, communities in Texas - like Pasadena - won’t have access to the innovative technology and benefits that 5G will embolden.

Research has found that 78 percent of Texans support their city leadership taking faster action to implement 5G technology. Yet Pasadena city officials have spent countless hours and financial resources since September 2020 fighting a lawsuit to prevent 5G installations in this community. Those dollars could have been spent on real community needs like infrastructure, utilities and public works. Pasadena is now behind its peers across the greater Houston area, where we have witnessed thousands of successful deployments of this necessary communications infrastructure. This puts Pasadena at a disadvantage as a great place to do business and improve the lives of residents.

It’s time for Pasadena to embrace the smart city infrastructure of the future. Other Texas cities like in Houston, Dallas and San Antonio, or even neighboring La Porte, have initiated smart policies that have encouraged connectivity in their communities as well as investments from industry. Unfortunately, Pasadena’s connectivity and infrastructure are being impeded by local politics. Every stakeholder should be at the table: industry, city officials, businesses, and most importantly, the local community, to support the expansion of the local 5G network.

------

Scott Dunaway is a spokesperson for the Texas 5G Alliance.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston researchers develop dissolvable implant for targeted cancer drug delivery

cancer research

Researchers at Houston Methodist have developed a biodegradable implant that can be used to safely and consistently deliver drug treatments to tumors and then dissolve without the need for further surgery.

The implant is only the size of a grain of rice, but its potential is staggering. The biodegradable nanofibrous drug-eluting seed (b-NDES) works as a reservoir parked inside a soft tumor, where it can slowly release immune-stimulating drugs over time. This overcomes a consistent problem with drugs such as immune checkpoint inhibitors. Normal systemic administration sees comparatively little of the drug making its way to the tumor, with most of it circulating throughout the body. The b-NDES is like deploying a small guerrilla fighting force embedded in enemy territory, doing maximum damage to the entrenched tumor.

"To improve cancer treatment, we're trying to start a fire inside the tumor itself," Corrine Chua, associate professor in the Center for BioNanoengineering at Houston Methodist Research Institute, said in a news release. "By activating immune cells directly within the tumor microenvironment, those cells can then travel throughout the body and seek out cancer wherever it exists. The b-NDES platform was developed to help keep therapeutic drugs concentrated inside tumors while minimizing exposure to healthy tissues.”

Chua co-led the study with Alessandro Grattoni, chair and director of the Center for BioNanoengineering at Houston Methodist Research Institute.

The study included support from the Nancy Owens Breast Cancer Foundation and the National Institutes of Health/National Cancer Institute.

Chau and Grattoni used preclinical models of triple-negative breast cancer, an aggressive form of cancer that is estrogen receptor-negative, progesterone receptor-negative and HER2-negative. Because of the receptor negativity, some popular treatments like tamoxifen and trastuzumab are ineffective. Chemotherapy has been shown to be the best course of action.

The b-NDES implant is deployed alongside radiation drugs. It keeps the drugs focused on the tumor, reducing the amount of harmful side effects typically seen when drugs are circulated more widely in the body. In 60 percent of the models, tumors were eliminated and did not cause side effects beyond the tumor site. Once the drugs have been deployed, the implant breaks down naturally.

While promising, more research will have to be done to expand use to other tumor types.

"Although the study focused on triple-negative breast cancer models, the approach could have broader applications for solid tumors," Grattoni added in the release. "It could potentially be used in cancers where there is a tumor lesion accessible for placement, including pancreatic or lung cancers."

New Houston platform Same Day Reels launches for on-demand content creation

In The Moment

If an event doesn't happen on Instagram, did it even really happen? In today's social media-driven age of branding and audience engagement, the answer increasingly is no.

Houston entrepreneur Karen De Amat is looking to fill the online content creation needs of companies with her new venture, Same Day Reels, which launched in early August. It will serve as a platform to connect companies and brands with talent that can help turn an event into a viral moment as it is happening.

"Events move quickly, and social media moves even faster,” said De Amat. “Same Day Reels was built to help brands capture the moment while it still matters. We are creating a more efficient way for businesses and creators to work together. Brands need content faster, and creators need more opportunities to turn their talent into real work. Same Day Reels brings those needs together.”

The company is focused on adding livestreams and concurrent short video content to "activations, launches, fundraisers, grand openings, conferences, hospitality experiences, and private celebrations." Such content can significantly increase the visibility of a product or brand according to digital marketing brands like Wyzowl, whose data found 63 percent of people in 2026 prefer to learn about new products via short video.

Packages offered by Same Day Reels will include filming, editing, and publishing content within hours of the targeted event.

De Amat says that her content creation platform will be a way to preserve the excitement of events and launches by enshrining them with immediate social media-driven memories.

“Event content is no longer just something you post after the fact,” De Amat said. “It is part of how people experience, remember and share the moment.”

Previously, De Amat is also the founder and CEO of Social Behavior, an influencer marketing company she launched from her home in 2014. It quickly garnered an array of clients and thrust De Amat into the spotlight, including numerous appearances on Fox 26's The Isiah Factor. Influencer Marketing Hub named her one of the top CEOs of influencer marketing companies in Houston in 2025.

---

This article originally appeared on CultureMap.com.

Bristol Myers Squibb to build $2.3B Houston pharma manufacturing campus

coming soon

New Jersey-based pharmaceutical giant Bristol Myers Squibb Co. has officially named Houston as the home of its new state-of-the-art manufacturing site.

The 60,000-square-foot facility represents a $2.3 billion investment, according to a news release. It is expected to create 500 skilled jobs and will be located in Houston's Generation Park.

BMS first announced that it was considering Houston among 16 other cities for the facility in May. The new hub will manufacture small molecule, biologic and antibody-drug conjugates and is part of a $40 billion commitment to invest in the United States over five years. Construction is slated to begin next year, with the facility coming online in 2030.

"We're building the domestic manufacturing capabilities needed to deliver the next generation of medicines and support future scientific breakthroughs. Houston and the state of Texas offer the talent, infrastructure, and partnership needed to help bring that vision to life," Christopher Boerner, CEO and board chair of BMS, said in the release.

The new facility will feature a modular, multi-modal design, which will allow the company to reconfigure and add to its manufacturing capabilities over time. BMS says it expects the facility to "(grow) in scale and capability well beyond its opening configuration."

"Our decision to build this state-of-the-art manufacturing campus in Houston, Texas, reflects our confidence in the region’s ability to support a world-class, digitally advanced supply operation,” Karin Shanahan, EVP and chief supply chain and operations officer of BMS, added in the release. “This facility is designed to deliver the speed, quality, and reliability that patients depend on, combining flexible, modular manufacturing with advanced digital capabilities to ensure consistent supply across multiple modalities. It strengthens our ability to operate with resilience and positions us to reliably deliver medicines to patients today while adapting future demands.”

Texas Gov. Greg Abbott shared that the state has granted BMS a $4.89 million Texas Enterprise Fund (TEF) grant for the project. TEF grants, administered by the Texas Economic Development & Tourism Office, support business relocation or expansion projects that create "new, good-paying jobs in the community and attract significant new capital investment to the state." The development is also a qualified project under the Texas Jobs, Energy, Technology, and Innovation (JETI) program.

“Texas is a global hub for life sciences, where today’s innovations shape the future of healthcare,” Abbott said in a news release. “This $2.3 billion investment by Bristol Myers Squibb in the dynamic biotech ecosystem in Houston is a testament to the depth of our skilled workforce and the pipeline of talent coming through our nation-leading technical colleges and research universities. With lower operating costs and easy access to markets across the U.S. and the world, Texas drives affordability for consumers.”

"Bristol Myers Squibb’s announcement is a tremendous win for Texas and the Houston region, further reinforcing our position as a premier destination for life sciences and advanced manufacturing,” added Greater Houston Partnership President and CEO Steve Kean.

Last fall, Eli Lilly and Co. selected Generation Park, a 4,300-acre, master-planned commercial district near Lake Houston, for its $6.5 billion manufacturing plant. More than 300 locations in the U.S. competed for the factory. Read more here.

View All Listings